Masanori Kuroha

Daiichi-Sankyo (Japan) — Japan

Medicine · Health Sciences

14h-index647citations24works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Mechanisms and Treatments(9), Botulinum Toxin and Related Neurological Disorders(9), Drug Transport and Resistance Mechanisms(8), Pharmacogenetics and Drug Metabolism(6), Peroxisome Proliferator-Activated Receptors(5)

Publications24 total

Usefulness of Mirogabalin in Central Neuropathic Pain After Stroke: Post Hoc Analysis of a Phase 3 Study by Stroke Type and Location
Pain and Therapy·2024Open Access
Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia
Pain and Therapy·2023· 13 citedOpen Access
Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury
Neurology·2022· 64 citedOpen Access
A review of a new voltage-gated Ca<sup>2+</sup> channel α<sub>2</sub>δ ligand, mirogabalin, for the treatment of peripheral neuropathic pain
Expert Opinion on Pharmacotherapy·2021· 26 citedOpen Access
Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies
Clinical Therapeutics·2021· 44 citedOpen Access
Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study
Pain and Therapy·2020· 24 citedOpen Access
Long‐term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain
Journal of Diabetes Investigation·2019· 46 citedOpen Access
Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients
Journal of Diabetes Investigation·2019· 126 citedOpen Access
Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige&lt;sup&gt;®&lt;/sup&gt; tablets 2.5 mg∙5 mg∙10 mg∙15 mg)
Folia Pharmacologica Japonica·2019· 10 citedOpen Access
Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization
Bioorganic & Medicinal Chemistry·2018· 7 cited
Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification
Bioorganic & Medicinal Chemistry·2018· 12 citedOpen Access
Synthesis and biological evaluation of novel (−)-cercosporamide derivatives as potent selective PPARγ modulators
European Journal of Medicinal Chemistry·2012· 17 citedOpen Access
Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor .GAMMA. Ligand, Cerco-A
Biological and Pharmaceutical Bulletin·2011· 16 citedOpen Access
Discovery of a novel selective PPARγ modulator from (−)-Cercosporamide derivatives
Bioorganic & Medicinal Chemistry Letters·2010· 16 citedOpen Access
ChemInform Abstract: (‐)‐Cercosporamide Derivatives as Novel Antihyperglycemic Agents.
ChemInform·2009
(−)-Cercosporamide derivatives as novel antihyperglycemic agents
Bioorganic & Medicinal Chemistry Letters·2008· 9 citedOpen Access
Effect of oral administration of clinically relevant doses of dexamethasone on regulation of cytochrome P450 subfamilies in hepatic microsomes from dogs and rats
American Journal of Veterinary Research·2006· 12 citedOpen Access
Clinical Oral Doses of Dexamethasone Decreases Intrinsic Clearance of Quinidine, A Cytochrome P450 3A Substrate in Dogs
Journal of Veterinary Medical Science·2006· 10 citedOpen Access
Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P‐450 1A activities in dogs
Journal of Veterinary Pharmacology and Therapeutics·2005· 39 cited
Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs
Journal of Veterinary Pharmacology and Therapeutics·2004· 18 cited
page 1 of 2Next →

Frequent Co-authors

Kazushi Araki(7), Jun Ohsumi(7), Minoru Shimoda(5), Eiichi KOKUE(5), Akihiro Furukawa(5), Yumi Matsui(5), Masayuki Baba(4), Shoichi Ohwada(4), Tsuyoshi Arita(4), Susumu Satoh(4), Jun Tanaka(4), Satoko Wakimoto(4), Norimitsu Matsui(3), Yosuke Wasaki(3), Takahiro Ushida(3), Yoichi Katayama(3), Yoshihiro Kakehi(3), Kunika Kikumori(3), M. Shimoda(3), Makoto Mori(3)